Prevalence of kidney disease in HIV-infected and uninfected Rwandan Women

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Wyatt, Christina M ^a   Shi, Qiuhu ^b   Novak, James E ^c   Hoover, Donald R ^d   Szczech, Lynda ^e   Mugabo, Jules Semahore ^f   Binagwaho, Agnes ^g,h   Cohen, Mardge ⁱ   Mutimura, Eugene ^j   Anastos, Kathryn ^k  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c HENRY FORD HEALTH SYSTEM   (United States)

^d RUTGERS UNIVERSITY   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY OF MARYLAND   (United States)

^g Ministry of Health   (Rwanda)

^h HARVARD MEDICAL SCHOOL   (United States)

ⁱ Cook County Bureau of Health Services ^*  (United States)

^j Women's Equity in Access to Care and Treatment   (Rwanda)

^k ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AFRICAN AMERICAN; ARTICLE; CLINICAL EVALUATION; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; FEMALE; GLOMERULUS FILTRATION RATE; HIV ASSOCIATED NEPHROPATHY; HUMAN; MAJOR CLINICAL STUDY; PATIENT ASSESSMENT; PREVALENCE; PROSPECTIVE STUDY; PROTEINURIA; RWANDA; DEMOGRAPHY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY DISEASE; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; DEMOGRAPHY; FEMALE; GLOMERULAR FILTRATION RATE; HIV INFECTIONS; HUMANS; KIDNEY DISEASES; MULTIVARIATE ANALYSIS; PREVALENCE; RWANDA;

EID: 79953149257     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018352     Document Type: Article

References (28)

1. UNAIDS (2008) UNAIDS/WHO AIDS Epidemic Update: 2008.
2. Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, et al. (2008) MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 40: 1175-1184.
3. Kao WH, Klag MJ, Meoni LA, Reich D, Berthier-Schaad Y, et al. (2008) MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 40: 1185-1192.
4. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, et al. (2010) Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329: 841-845.
5. Choi AI, Rodriguez RA, Bacchetti P, Bertenthal D, Volberding PA, et al. (2007) Racial Differences in End-Stage Renal Disease Rates in HIV Infection versus Diabetes. J Am Soc Nephrol 18: 2968-2974.
6. Lucas GM, Lau B, Atta MG, Fine DM, Keruly J, et al. (2008) Chronic Kidney Disease Incidence, and Progression to End-Stage Renal Disease, in HIV-Infected Individuals: A Tale of Two Races. J Infect Dis 197: 1548-1557.
7. Wools-Kaloustian K, Gupta SK, Muloma E, Owino-Ong'or W, Sidle J, et al. (2007) Renal disease in an antiretroviral-naive HIV-infected outpatient population in Western Kenya. Nephrol Dial Transplant 22: 2208-2212.
8. Emem CP, Arogundade F, Sanusi A, Adelusola K, Wokoma F, et al. (2008) Renal disease in HIV-seropositive patients in Nigeria: an assessment of prevalence, clinical features and risk factors. Nephrol Dial Transplant 23: 741-746.
9. Reid A, Stohr W, Walker AS, Williams IG, Kityo C, et al. (2008) Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy. Clin Infect Dis 46: 1271-1281.
10. Mulenga LB, Kruse G, Lakhi S, Cantrell RA, Reid SE, et al. (2008) Baseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, Zambia. AIDS 22: 1821-1827.
11. Gupta SK, Eustace JA, Winston JA, Boydstun II, Ahuja TS, et al. (2005) Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 40: 1559-1585.
12. Kotler DP, Burastero S, Wang J, Pierson RNJ, (1996) Prediction of body cell mass, fat-free mass, and total body water with bioelectrical impedance analysis: effects of race, sex, and disease. Am J Clin Nutr 64: 489S-497S.
13. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, et al. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470.
14. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AFr, et al. (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612.
15. Cockcroft DW, Gault MH, (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41.
16. van Deventer HE, George JA, Paiker JE, Becker PJ, Katz IJ, (2008) Estimating glomerular filtration rate in black South Africans by use of the modification of diet in renal disease and Cockcroft-Gault equations. Clin Chem 54: 1197-1202.
17. Eastwood JB, Kerry SM, Plange-Rhule J, Micah FB, Antwi S, et al. (2010) Assessment of GFR by four methods in adults in Ashanti, Ghana: the need for an eGFR equation for lean African populations. Nephrol Dial Transplant 25: 2178-2187.
18. Wyatt CM, Winston JA, Malvestutto CD, Fishbein DA, Barash I, et al. (2007) Chronic kidney disease in HIV infection: an urban epidemic. AIDS 21: 2101-2103.
19. Lucas GM, Clarke W, Kagaayi J, Atta MG, Fine DM, et al. (2010) Decreased Kidney Function in a Community-based Cohort of HIV-Infected and HIV-Negative Individuals in Rakai, Uganda. J Acquir Immune Defic Syndr 55: 491-494.
20. Han TM, Naicker S, Ramdial PK, Assounga AG, (2006) A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa. Kidney Int 69: 2243-2250.
21. Arendse CG, Wearne N, Okpechi IG, Swanepoel CR, (2010) The acute, the chronic and the news of HIV-related renal disease in Africa. Kidney Int 78: 239-245.
22. Mugyenyi P, Walker AS, Hakim J, Munderi P, Gibb DM, et al. (2010) Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. Lancet 375: 123-131.
23. World Health Organization (2006) Patient monitoring guidelines for HIV care and antiretroviral therapy (ART). http://www.who.int/hiv/pub/imai/patientguide/en/index.html. Accessed 2011 March 7.
24. Peters PJ, Moore DM, Mermin J, Brooks JT, Downing R, et al. (2008) Antiretroviral therapy improves renal function among HIV-infected Ugandans. Kidney Int 74: 925-929.
25. Stohr W, Walker AS, Munderi P, Tugume S, Gilks CF, et al. (2008) Estimating glomerular filtration rate in HIV-infected adults in Africa: comparison of Cockcroft-Gault and Modification of Diet in Renal Disease formulae. Antivir Ther 13: 761-770.
26. Szczech LA, Hoover DR, Feldman JG, Cohen MH, Gange SJ, et al. (2004) Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy. Clin Infect Dis 39: 1199-1206.
27. Wyatt CM, Hoover DR, Shi Q, Seaberg E, Wei C, et al. (2010) Microalbuminuria Is Associated With All-Cause and AIDS Mortality in Women With HIV Infection. J Acquir Immune Defic Syndr 55: 73-77.
28. Wyatt CM, Hoover DR, Shi Q, Tien PC, Karim R, et al. (2011) Pre-existing albuminuria predicts AIDS and non-AIDS mortality in women initiating antiretroviral therapy. Antivir Ther in press.